Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Nifedipine API market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Nifedipine API are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Nifedipine API market segmented into
98% Nifedipine API
99% Nifedipine API
99.9% Nifedipine API

Based on the end-use, the global Nifedipine API market classified into
Controlled Release Tablets
Extended Action Tablets
Modified Release Capsule

Based on geography, the global Nifedipine API market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Bayer AG
ZACH SYSTEM SPA
Teva Group
Dipharma Francis S.r.l.
Delmar Chemicals Inc.
Moehs Iberica S.L.
Sumika Fine Chemicals Co., Ltd.
CIPLA Ltd
Dipharma Francis S.r.l
Tecoland Corp
Zhong'an Pharmaceutical
Siyao Pharmaceuticals
Xiyue Pharmaceutical
Qingyang Pharmaceutical
Luyin Pharmaceutical

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NIFEDIPINE API INDUSTRY
2.1 Summary about Nifedipine API Industry
2.2 Nifedipine API Market Trends
2.2.1 Nifedipine API Production & Consumption Trends
2.2.2 Nifedipine API Demand Structure Trends
2.3 Nifedipine API Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 98% Nifedipine API
4.2.2 99% Nifedipine API
4.2.3 99.9% Nifedipine API
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Controlled Release Tablets
4.3.2 Extended Action Tablets
4.3.3 Modified Release Capsule
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 98% Nifedipine API
5.2.2 99% Nifedipine API
5.2.3 99.9% Nifedipine API
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Controlled Release Tablets
5.3.2 Extended Action Tablets
5.3.3 Modified Release Capsule
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 98% Nifedipine API
6.2.2 99% Nifedipine API
6.2.3 99.9% Nifedipine API
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Controlled Release Tablets
6.3.2 Extended Action Tablets
6.3.3 Modified Release Capsule
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 98% Nifedipine API
7.2.2 99% Nifedipine API
7.2.3 99.9% Nifedipine API
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Controlled Release Tablets
7.3.2 Extended Action Tablets
7.3.3 Modified Release Capsule
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 98% Nifedipine API
8.2.2 99% Nifedipine API
8.2.3 99.9% Nifedipine API
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Controlled Release Tablets
8.3.2 Extended Action Tablets
8.3.3 Modified Release Capsule
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 98% Nifedipine API
9.2.2 99% Nifedipine API
9.2.3 99.9% Nifedipine API
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Controlled Release Tablets
9.3.2 Extended Action Tablets
9.3.3 Modified Release Capsule
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bayer AG
10.1.2 ZACH SYSTEM SPA
10.1.3 Teva Group
10.1.4 Dipharma Francis S.r.l.
10.1.5 Delmar Chemicals Inc.
10.1.6 Moehs Iberica S.L.
10.1.7 Sumika Fine Chemicals Co., Ltd.
10.1.8 CIPLA Ltd
10.1.9 Dipharma Francis S.r.l
10.1.10 Tecoland Corp
10.1.11 Zhong'an Pharmaceutical
10.1.12 Siyao Pharmaceuticals
10.1.13 Xiyue Pharmaceutical
10.1.14 Qingyang Pharmaceutical
10.1.15 Luyin Pharmaceutical
10.2 Nifedipine API Sales Date of Major Players (2017-2020e)
10.2.1 Bayer AG
10.2.2 ZACH SYSTEM SPA
10.2.3 Teva Group
10.2.4 Dipharma Francis S.r.l.
10.2.5 Delmar Chemicals Inc.
10.2.6 Moehs Iberica S.L.
10.2.7 Sumika Fine Chemicals Co., Ltd.
10.2.8 CIPLA Ltd
10.2.9 Dipharma Francis S.r.l
10.2.10 Tecoland Corp
10.2.11 Zhong'an Pharmaceutical
10.2.12 Siyao Pharmaceuticals
10.2.13 Xiyue Pharmaceutical
10.2.14 Qingyang Pharmaceutical
10.2.15 Luyin Pharmaceutical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
1.Table Nifedipine API Product Type Overview
2.Table Nifedipine API Product Type Market Share List
3.Table Nifedipine API Product Type of Major Players
4.Table Brief Introduction of Bayer AG
5.Table Brief Introduction of ZACH SYSTEM SPA
6.Table Brief Introduction of Teva Group
7.Table Brief Introduction of Dipharma Francis S.r.l.
8.Table Brief Introduction of Delmar Chemicals Inc.
9.Table Brief Introduction of Moehs Iberica S.L.
10.Table Brief Introduction of Sumika Fine Chemicals Co., Ltd.
11.Table Brief Introduction of CIPLA Ltd
12.Table Brief Introduction of Dipharma Francis S.r.l
13.Table Brief Introduction of Tecoland Corp
14.Table Brief Introduction of Zhong'an Pharmaceutical
15.Table Brief Introduction of Siyao Pharmaceuticals
16.Table Brief Introduction of Xiyue Pharmaceutical
17.Table Brief Introduction of Qingyang Pharmaceutical
18.Table Brief Introduction of Luyin Pharmaceutical
19.Table Products & Services of Bayer AG
20.Table Products & Services of ZACH SYSTEM SPA
21.Table Products & Services of Teva Group
22.Table Products & Services of Dipharma Francis S.r.l.
23.Table Products & Services of Delmar Chemicals Inc.
24.Table Products & Services of Moehs Iberica S.L.
25.Table Products & Services of Sumika Fine Chemicals Co., Ltd.
26.Table Products & Services of CIPLA Ltd
27.Table Products & Services of Dipharma Francis S.r.l
28.Table Products & Services of Tecoland Corp
29.Table Products & Services of Zhong'an Pharmaceutical
30.Table Products & Services of Siyao Pharmaceuticals
31.Table Products & Services of Xiyue Pharmaceutical
32.Table Products & Services of Qingyang Pharmaceutical
33.Table Products & Services of Luyin Pharmaceutical
34.Table Market Distribution of Major Players
35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
37.Table Global Nifedipine API Market Forecast (Million USD) by Region 2021f-2026f
38.Table Global Nifedipine API Market Forecast (Million USD) Share by Region 2021f-2026f
39.Table Global Nifedipine API Market Forecast (Million USD) by Demand 2021f-2026f
40.Table Global Nifedipine API Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Nifedipine API Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Nifedipine API Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Nifedipine API Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Nifedipine API Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Nifedipine API Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Nifedipine API Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Nifedipine API Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure 98% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure 99% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure 99.9% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Controlled Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Extended Action Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Modified Release Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure 98% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure 99% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure 99.9% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Controlled Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Extended Action Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Modified Release Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure 98% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure 99% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure 99.9% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Controlled Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Extended Action Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Modified Release Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure 98% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure 99% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure 99.9% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Controlled Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Extended Action Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Modified Release Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure 98% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure 99% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure 99.9% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Controlled Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Extended Action Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Modified Release Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure 98% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure 99% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure 99.9% Nifedipine API Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Controlled Release Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Extended Action Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Modified Release Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Nifedipine API Sales Revenue (Million USD) of Bayer AG 2017-2020e
72.Figure Nifedipine API Sales Revenue (Million USD) of ZACH SYSTEM SPA 2017-2020e
73.Figure Nifedipine API Sales Revenue

2023-2028 Global and Regional Nifedipine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Nifedipine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field eva...

(COVID Version) Global Nifedipine API Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use...

Summary The report forecast global Nifedipine API market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation. The report offers detailed coverage of Nifedipine API industry and main market trends with impact of cor...

Global Nifedipine API Market Research Report 2016-2026...

Summary The global Nifedipine API market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing mar...

COVID-19 Global & USA Nifedipine API Market Research by Company, Type & Application 2015-2026...

Summary HeyReport estimates that the Nifedipine API market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025. In this repo...

COVID-19 Global & USA Nifedipine Market Research by Company, Type & Application 2015-2026...

Summary HeyReport estimates that the Nifedipine market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025. In this report, ...

Global Nifedipine Market Analysis 2016-2020 and Forecast 2021-2026...

Snapshot The global Nifedipine market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, ...

2021-2027 Global and Regional Nifedipine Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report Standard Version...

The research team projects that the Nifedipine market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027. The prime objective of this report is to help the user unders...

COVID-19 Global & China Nifedipine API Market Research by Company, Type & Application 2015-2026...

Summary HeyReport estimates that the Nifedipine API market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025. In this repo...

COVID-19 Global & China Nifedipine Market Research by Company, Type & Application 2015-2026...

Summary HeyReport estimates that the Nifedipine market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025. In this report, ...

Nifedipine API Market Status and Trend Analysis 2017-2026 (COVID-19 Version)...

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use...